Cartesian Therapeutics Inc (RNAC)
25.60
+1.17
(+4.79%)
USD |
NASDAQ |
May 03, 16:00
25.47
-0.13
(-0.51%)
After-Hours: 20:00
Cartesian Therapeutics Profit Margin (Quarterly): -2.15K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -2.15K% |
September 30, 2023 | -137.4% |
June 30, 2023 | -216.9% |
March 31, 2023 | -364.8% |
December 31, 2022 | 35.09% |
September 30, 2022 | -38.11% |
June 30, 2022 | 21.90% |
March 31, 2022 | 84.64% |
December 31, 2021 | 40.88% |
September 30, 2021 | -73.26% |
June 30, 2021 | 23.22% |
March 31, 2021 | -222.6% |
December 31, 2020 | -129.2% |
September 30, 2020 | -209.4% |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | -223.7% |
September 30, 2019 |
Date | Value |
---|---|
June 30, 2019 | -126.1K% |
March 31, 2019 | -120.7K% |
December 31, 2018 | -1.62K% |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | -115.0K% |
September 30, 2017 | -54.36K% |
June 30, 2017 | -61.41K% |
March 31, 2017 | -11.05K% |
December 31, 2016 | -480.6% |
September 30, 2016 | -737.4% |
June 30, 2016 | -343.2% |
March 31, 2016 | -358.0% |
December 31, 2015 | -320.9% |
September 30, 2015 | -356.3% |
June 30, 2015 | -555.6% |
March 31, 2015 | -554.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-126.1K%
Minimum
Jun 2019
84.64%
Maximum
Mar 2022
-8.10K%
Average
-133.3%
Median
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
Return on Assets | -126.0% |
Operating Margin (Quarterly) | -439.5% |
Return on Net Operating Assets | -359.1% |